Levocetirizine Dihydrochloride
Product Images NDC 53217-375

2 FDA label images from Aidarex Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 53217-375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Chemical Structure (Levocetirizine Di 5mg 1)

Image Of Chemical Structure (Levocetirizine Di 5mg 1)
Chemical structure depicting Levocetirizine Dihydrochloride, showing its molecular arrangement including aromatic rings, chlorine, piperazine ring, and hydrochloride components.*
FDA Label Image

53217-0375_levocetirizine-di_5mg (Levocetirizine Di 5mg 2)

53217-0375_levocetirizine-di_5mg (Levocetirizine Di 5mg 2)
Levocetirizine Dihydrochloride 5 mg tablets in a blister pack containing 30 tablets. The label includes active ingredient information, dosing instructions, and packaging details. The product is labeled by Aidarex Pharmaceuticals LLC and lists NDC 53217-0375-30. The blister pack displays individual tablet compartments with clear markings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.